UCREST BERHAD

KLSE: 0005 (UCREST)

Last update: 11 hours ago

0.075

-0.01 (-6.25%)

Previous Close 0.080
Open 0.080
Volume 820,400
Avg. Volume (3M) 2,156,206
Market Cap 55,787,060
Price / Earnings (TTM) 7.50
Price / Sales 3.18
Price / Book 1.32
52 Weeks Range
0.065 (-13%) — 0.115 (53%)
Profit Margin 21.74%
Operating Margin (TTM) 25.39%
Diluted EPS (TTM) 0.010
Quarterly Revenue Growth (YOY) 12.40%
Quarterly Earnings Growth (YOY) -14.20%
Total Debt/Equity (MRQ) 0.13%
Current Ratio (MRQ) 5.10
Operating Cash Flow (TTM) -1.93 M
Levered Free Cash Flow (TTM) -2.44 M
Return on Assets (TTM) 3.86%
Return on Equity (TTM) 9.21%

Market Trend

Short Term Medium Term
Industry Health Information Services (MY) Mixed Mixed
Health Information Services (Global) Bearish Mixed
Stock UCREST - -

AIStockmoo Score

0.6
Analyst Consensus 0.0
Insider Activity NA
Price Volatility 0.5
Technical Moving Averages 2.5
Technical Oscillators -0.5
Average 0.63

UCrest Bhd is a technology provider company that engages in network design, product development, and software development. The firm provider of Cloud Hospital and mobile health services. The company offers an i-Medic platform for diagnosis, management, and treatment of chronic diseases such as cardiovascular diseases (CVD), cancer, diabetes, hypertension, sleep apnea, stroke rehabilitation, and other diseases.

Sector Healthcare
Industry Health Information Services
Investment Style Small Core
% Held by Insiders 35.38%

No data within this time range.

No data within this time range.

Date Type Details
12 Nov 2025 Announcement General Meetings: Outcome of Meeting
12 Nov 2025 Announcement General Meetings: Outcome of Meeting
12 Nov 2025 Announcement POST AGM PRESS RELEASE
10 Nov 2025 Announcement Change in Nomination Committee - MISS CHUAN TSUI JU
10 Nov 2025 Announcement Change in Nomination Committee - DATO DR DATO' DR. MOHD FIKRI BIN ABDULLAH
10 Nov 2025 Announcement Change in Audit Committee - ENCIK ABDUL RAZAK BIN DATO' HAJI IPAP
10 Nov 2025 Announcement Change in Boardroom - MISS CHUAN TSUI JU
10 Nov 2025 Announcement Change in Audit Committee - DATO' DR DATO' DR. MOHD FIKRI BIN ABDULLAH
10 Nov 2025 Announcement CHANGES IN BOARDROOM
29 Oct 2025 Announcement Quarterly rpt on consolidated results for the financial period ended 31/08/2025
28 Oct 2025 Announcement CIRCULAR TO SHAREHOLDERS IN RELATION TO THE PROPOSED ESTABLISHMENT OF AN EMPLOYEES' SHARE OPTION SCHEME ("ESOS") OF UP TO 30% OF THE TOTAL NUMBER OF ISSUED SHARES IN UCREST BERHAD (EXCLUDING TREASURY SHARES, IF ANY) AT ANY ONE TIME DURING THE DURATION OF THE ESOS FOR THE ELIGIBLE DIRECTORS AND EMPLOYEES OF UCREST BERHAD AND ITS SUBSIDIARIES (EXCLUDING DORMANT SUBSIDIARIES, IF ANY)
27 Oct 2025 Announcement General Meetings: Notice of Meeting
24 Oct 2025 Announcement MULTIPLE PROPOSALS
14 Oct 2025 Announcement NEWS RELEASE - UCrest Berhad Awarded Its First Patent in Taiwan for AI-Powered Digital Health Platform, iMedic
13 Oct 2025 Announcement MULTIPLE PROPOSALS
10 Oct 2025 Announcement MULTIPLE PROPOSALS
10 Oct 2025 Announcement UCREST BERHAD ("UCREST" OR THE "COMPANY") - TERMINATION OF EXISTING EMPLOYEES' SHARE OPTION SCHEME ("ESOS") OF THE COMPANY
30 Sep 2025 Announcement Annual Report & CG Report - 2025
30 Sep 2025 Announcement CIRCULAR TO SHAREHOLDERS IN RELATION TO THE PROPOSED RENEWAL OF THE EXISTING SHAREHOLDERS' MANDATE FOR RECURRENT RELATED PARTY TRANSACTIONS OF A REVENUE OR TRADING NATURE
29 Sep 2025 Announcement General Meetings: Notice of Meeting
19 Sep 2025 Announcement UCREST BERHAD ("UCREST" OR THE "COMPANY") - PROPOSED RENEWAL OF THE EXISTING SHAREHOLDERS' MANDATE FOR RECURRENT RELATED PARTY TRANSACTIONS OF A REVENUE OR TRADING NATURE ("PROPOSED MANDATE")
Show more

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria